Could a once-every-few-weeks IV infusion tame rheumatoid arthritis?
NCT ID NCT07704580
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether giving sarilumab (Kevzara) through an IV with longer intervals between doses is safe and works well for adults with moderate-to-severe rheumatoid arthritis. Participants receive the drug intravenously, with or without other standard arthritis medications. Researchers measure drug levels in the blood and monitor for side effects over about six months of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental intravenous form of the drug sarilumab (also known as Kevzara)
- What this could lead to
- If successful, this could offer people with rheumatoid arthritis a more convenient dosing option with fewer injections.
- What could go wrong
- This is an early-phase study with a small number of participants, so results may not apply broadly. The longer dosing intervals might not control symptoms as effectively as the standard regimen.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ClinRx Research - Plano- Site Number : 8400015
RECRUITINGPlano, Texas, 75023, United States
-
Encore Medical Research - Hollywood- Site Number : 8400010
RECRUITINGHollywood, Florida, 33024, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Could cord cell secretions ease arthritis pain?
- Which RA drug works best after the first one fails? a major trial aims to find out
- CT scans track hip implant movement to predict Long-Term stability
- Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors